Loading…

Stabilization of Kv1.5 channel protein by bepridil through its action as a chemical chaperone

While bepridil has been reported to alter the stability of ion channel proteins, the precise mechanism of action remains unclear. We examined the effect of bepridil on the stability of Kv1.5 channel proteins expressed in COS7 cells. Bepridil at 0.3–30μM increased the protein level of Kv1.5 channels...

Full description

Saved in:
Bibliographic Details
Published in:European journal of pharmacology 2012-12, Vol.696 (1-3), p.28-34
Main Authors: Suzuki, Sayuri, Kurata, Yasutaka, Li, Peili, Notsu, Tomomi, Hasegawa, Akira, Ikeda, Nobuhito, Kato, Masaru, Miake, Junichiro, Sakata, Shinji, Shiota, Goshi, Yoshida, Akio, Ninomiya, Haruaki, Higaki, Katsumi, Yamamoto, Kazuhiro, Shirayoshi, Yasuaki, Hisatome, Ichiro
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c507t-d2ab9451c1ef9af8aadd3a041bff4ea7f8e8d2539456be2c2aee813036980d83
cites cdi_FETCH-LOGICAL-c507t-d2ab9451c1ef9af8aadd3a041bff4ea7f8e8d2539456be2c2aee813036980d83
container_end_page 34
container_issue 1-3
container_start_page 28
container_title European journal of pharmacology
container_volume 696
creator Suzuki, Sayuri
Kurata, Yasutaka
Li, Peili
Notsu, Tomomi
Hasegawa, Akira
Ikeda, Nobuhito
Kato, Masaru
Miake, Junichiro
Sakata, Shinji
Shiota, Goshi
Yoshida, Akio
Ninomiya, Haruaki
Higaki, Katsumi
Yamamoto, Kazuhiro
Shirayoshi, Yasuaki
Hisatome, Ichiro
description While bepridil has been reported to alter the stability of ion channel proteins, the precise mechanism of action remains unclear. We examined the effect of bepridil on the stability of Kv1.5 channel proteins expressed in COS7 cells. Bepridil at 0.3–30μM increased the protein level of Kv1.5 channels in a concentration-dependent manner. Chase experiments showed that bepridil delayed the degradation process of Kv1.5 channel proteins in the same manner as a proteasomal inhibitor, MG132, did. Bepridil increased the immunofluorescent signal of Kv1.5 channel proteins in the endoplasmic reticulum (ER) and Golgi apparatus and on the cell surface. The cell fraction experiment also showed bepridil-induced increases in Kv1.5 in the ER, Golgi apparatus, and the cell membrane. Bepridil at a lower concentration of 1μM had no effect on the proteasome activity in vitro. A blocker of the ultrarapid delayed-rectifier K+ channel current, 4-aminopyridine (4AP), abolished bepridil-induced increases in Kv1.5. Kv1.5-medicated membrane currents measured as 4AP-sensitive currents were increased by bepridil. Taken together, we conclude that bepridil stabilizes Kv1.5 proteins at the ER through an action as a chemical chaperone, thereby increasing the density of Kv1.5 channels in the cell membrane.
doi_str_mv 10.1016/j.ejphar.2012.09.025
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1139620864</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014299912007996</els_id><sourcerecordid>1139620864</sourcerecordid><originalsourceid>FETCH-LOGICAL-c507t-d2ab9451c1ef9af8aadd3a041bff4ea7f8e8d2539456be2c2aee813036980d83</originalsourceid><addsrcrecordid>eNp9kMlOwzAQQC0EgrL8AUI-ckkYO6svSAixCSQO9IqsiT2hrtKk2CkSfD0uLRw52Yf3PJ7H2KmAVIAoL-YpzZcz9KkEIVNQKchih01EXakEKiF32QRA5IlUSh2wwxDmAFAoWeyzA5mBLLNKTtjry4iN69wXjm7o-dDyxw-RFtzMsO-p40s_jOR63nzyhpbeWdfxceaH1duMuzFwND8exlt0aOEMdmt5SX7o6ZjttdgFOtmeR2x6ezO9vk-enu8erq-eElNANSZWYqPyQhhBrcK2RrQ2Q8hF07Y5YdXWVFtZZJEpG5JGIlEtMshKVYOtsyN2vnk2_vZ9RWHUCxcMdR32NKyCFiJTpYS6zCOab1DjhxA8tToutUD_qQXodVc915uuet1Vg9Kxa9TOthNWzYLsn_QbMgKXG4Dimh-OvA7GUW_IOk9m1HZw_0_4BqZhi9A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1139620864</pqid></control><display><type>article</type><title>Stabilization of Kv1.5 channel protein by bepridil through its action as a chemical chaperone</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Suzuki, Sayuri ; Kurata, Yasutaka ; Li, Peili ; Notsu, Tomomi ; Hasegawa, Akira ; Ikeda, Nobuhito ; Kato, Masaru ; Miake, Junichiro ; Sakata, Shinji ; Shiota, Goshi ; Yoshida, Akio ; Ninomiya, Haruaki ; Higaki, Katsumi ; Yamamoto, Kazuhiro ; Shirayoshi, Yasuaki ; Hisatome, Ichiro</creator><creatorcontrib>Suzuki, Sayuri ; Kurata, Yasutaka ; Li, Peili ; Notsu, Tomomi ; Hasegawa, Akira ; Ikeda, Nobuhito ; Kato, Masaru ; Miake, Junichiro ; Sakata, Shinji ; Shiota, Goshi ; Yoshida, Akio ; Ninomiya, Haruaki ; Higaki, Katsumi ; Yamamoto, Kazuhiro ; Shirayoshi, Yasuaki ; Hisatome, Ichiro</creatorcontrib><description>While bepridil has been reported to alter the stability of ion channel proteins, the precise mechanism of action remains unclear. We examined the effect of bepridil on the stability of Kv1.5 channel proteins expressed in COS7 cells. Bepridil at 0.3–30μM increased the protein level of Kv1.5 channels in a concentration-dependent manner. Chase experiments showed that bepridil delayed the degradation process of Kv1.5 channel proteins in the same manner as a proteasomal inhibitor, MG132, did. Bepridil increased the immunofluorescent signal of Kv1.5 channel proteins in the endoplasmic reticulum (ER) and Golgi apparatus and on the cell surface. The cell fraction experiment also showed bepridil-induced increases in Kv1.5 in the ER, Golgi apparatus, and the cell membrane. Bepridil at a lower concentration of 1μM had no effect on the proteasome activity in vitro. A blocker of the ultrarapid delayed-rectifier K+ channel current, 4-aminopyridine (4AP), abolished bepridil-induced increases in Kv1.5. Kv1.5-medicated membrane currents measured as 4AP-sensitive currents were increased by bepridil. Taken together, we conclude that bepridil stabilizes Kv1.5 proteins at the ER through an action as a chemical chaperone, thereby increasing the density of Kv1.5 channels in the cell membrane.</description><identifier>ISSN: 0014-2999</identifier><identifier>EISSN: 1879-0712</identifier><identifier>DOI: 10.1016/j.ejphar.2012.09.025</identifier><identifier>PMID: 23026372</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>4-Aminopyridine - pharmacology ; Animals ; Bepridil ; Bepridil - pharmacology ; Cercopithecus aethiops ; Chemical chaperone ; COS Cells ; Endoplasmic Reticulum - drug effects ; Endoplasmic Reticulum - metabolism ; Golgi Apparatus - drug effects ; Golgi Apparatus - metabolism ; Kv1.5 channel ; Kv1.5 Potassium Channel - metabolism ; Membrane Transport Modulators - pharmacology ; Potassium Channel Blockers - pharmacology ; Protein stability ; Rats</subject><ispartof>European journal of pharmacology, 2012-12, Vol.696 (1-3), p.28-34</ispartof><rights>2012 Elsevier B.V.</rights><rights>Copyright © 2012 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c507t-d2ab9451c1ef9af8aadd3a041bff4ea7f8e8d2539456be2c2aee813036980d83</citedby><cites>FETCH-LOGICAL-c507t-d2ab9451c1ef9af8aadd3a041bff4ea7f8e8d2539456be2c2aee813036980d83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23026372$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Suzuki, Sayuri</creatorcontrib><creatorcontrib>Kurata, Yasutaka</creatorcontrib><creatorcontrib>Li, Peili</creatorcontrib><creatorcontrib>Notsu, Tomomi</creatorcontrib><creatorcontrib>Hasegawa, Akira</creatorcontrib><creatorcontrib>Ikeda, Nobuhito</creatorcontrib><creatorcontrib>Kato, Masaru</creatorcontrib><creatorcontrib>Miake, Junichiro</creatorcontrib><creatorcontrib>Sakata, Shinji</creatorcontrib><creatorcontrib>Shiota, Goshi</creatorcontrib><creatorcontrib>Yoshida, Akio</creatorcontrib><creatorcontrib>Ninomiya, Haruaki</creatorcontrib><creatorcontrib>Higaki, Katsumi</creatorcontrib><creatorcontrib>Yamamoto, Kazuhiro</creatorcontrib><creatorcontrib>Shirayoshi, Yasuaki</creatorcontrib><creatorcontrib>Hisatome, Ichiro</creatorcontrib><title>Stabilization of Kv1.5 channel protein by bepridil through its action as a chemical chaperone</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>While bepridil has been reported to alter the stability of ion channel proteins, the precise mechanism of action remains unclear. We examined the effect of bepridil on the stability of Kv1.5 channel proteins expressed in COS7 cells. Bepridil at 0.3–30μM increased the protein level of Kv1.5 channels in a concentration-dependent manner. Chase experiments showed that bepridil delayed the degradation process of Kv1.5 channel proteins in the same manner as a proteasomal inhibitor, MG132, did. Bepridil increased the immunofluorescent signal of Kv1.5 channel proteins in the endoplasmic reticulum (ER) and Golgi apparatus and on the cell surface. The cell fraction experiment also showed bepridil-induced increases in Kv1.5 in the ER, Golgi apparatus, and the cell membrane. Bepridil at a lower concentration of 1μM had no effect on the proteasome activity in vitro. A blocker of the ultrarapid delayed-rectifier K+ channel current, 4-aminopyridine (4AP), abolished bepridil-induced increases in Kv1.5. Kv1.5-medicated membrane currents measured as 4AP-sensitive currents were increased by bepridil. Taken together, we conclude that bepridil stabilizes Kv1.5 proteins at the ER through an action as a chemical chaperone, thereby increasing the density of Kv1.5 channels in the cell membrane.</description><subject>4-Aminopyridine - pharmacology</subject><subject>Animals</subject><subject>Bepridil</subject><subject>Bepridil - pharmacology</subject><subject>Cercopithecus aethiops</subject><subject>Chemical chaperone</subject><subject>COS Cells</subject><subject>Endoplasmic Reticulum - drug effects</subject><subject>Endoplasmic Reticulum - metabolism</subject><subject>Golgi Apparatus - drug effects</subject><subject>Golgi Apparatus - metabolism</subject><subject>Kv1.5 channel</subject><subject>Kv1.5 Potassium Channel - metabolism</subject><subject>Membrane Transport Modulators - pharmacology</subject><subject>Potassium Channel Blockers - pharmacology</subject><subject>Protein stability</subject><subject>Rats</subject><issn>0014-2999</issn><issn>1879-0712</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNp9kMlOwzAQQC0EgrL8AUI-ckkYO6svSAixCSQO9IqsiT2hrtKk2CkSfD0uLRw52Yf3PJ7H2KmAVIAoL-YpzZcz9KkEIVNQKchih01EXakEKiF32QRA5IlUSh2wwxDmAFAoWeyzA5mBLLNKTtjry4iN69wXjm7o-dDyxw-RFtzMsO-p40s_jOR63nzyhpbeWdfxceaH1duMuzFwND8exlt0aOEMdmt5SX7o6ZjttdgFOtmeR2x6ezO9vk-enu8erq-eElNANSZWYqPyQhhBrcK2RrQ2Q8hF07Y5YdXWVFtZZJEpG5JGIlEtMshKVYOtsyN2vnk2_vZ9RWHUCxcMdR32NKyCFiJTpYS6zCOab1DjhxA8tToutUD_qQXodVc915uuet1Vg9Kxa9TOthNWzYLsn_QbMgKXG4Dimh-OvA7GUW_IOk9m1HZw_0_4BqZhi9A</recordid><startdate>20121205</startdate><enddate>20121205</enddate><creator>Suzuki, Sayuri</creator><creator>Kurata, Yasutaka</creator><creator>Li, Peili</creator><creator>Notsu, Tomomi</creator><creator>Hasegawa, Akira</creator><creator>Ikeda, Nobuhito</creator><creator>Kato, Masaru</creator><creator>Miake, Junichiro</creator><creator>Sakata, Shinji</creator><creator>Shiota, Goshi</creator><creator>Yoshida, Akio</creator><creator>Ninomiya, Haruaki</creator><creator>Higaki, Katsumi</creator><creator>Yamamoto, Kazuhiro</creator><creator>Shirayoshi, Yasuaki</creator><creator>Hisatome, Ichiro</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20121205</creationdate><title>Stabilization of Kv1.5 channel protein by bepridil through its action as a chemical chaperone</title><author>Suzuki, Sayuri ; Kurata, Yasutaka ; Li, Peili ; Notsu, Tomomi ; Hasegawa, Akira ; Ikeda, Nobuhito ; Kato, Masaru ; Miake, Junichiro ; Sakata, Shinji ; Shiota, Goshi ; Yoshida, Akio ; Ninomiya, Haruaki ; Higaki, Katsumi ; Yamamoto, Kazuhiro ; Shirayoshi, Yasuaki ; Hisatome, Ichiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c507t-d2ab9451c1ef9af8aadd3a041bff4ea7f8e8d2539456be2c2aee813036980d83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>4-Aminopyridine - pharmacology</topic><topic>Animals</topic><topic>Bepridil</topic><topic>Bepridil - pharmacology</topic><topic>Cercopithecus aethiops</topic><topic>Chemical chaperone</topic><topic>COS Cells</topic><topic>Endoplasmic Reticulum - drug effects</topic><topic>Endoplasmic Reticulum - metabolism</topic><topic>Golgi Apparatus - drug effects</topic><topic>Golgi Apparatus - metabolism</topic><topic>Kv1.5 channel</topic><topic>Kv1.5 Potassium Channel - metabolism</topic><topic>Membrane Transport Modulators - pharmacology</topic><topic>Potassium Channel Blockers - pharmacology</topic><topic>Protein stability</topic><topic>Rats</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Suzuki, Sayuri</creatorcontrib><creatorcontrib>Kurata, Yasutaka</creatorcontrib><creatorcontrib>Li, Peili</creatorcontrib><creatorcontrib>Notsu, Tomomi</creatorcontrib><creatorcontrib>Hasegawa, Akira</creatorcontrib><creatorcontrib>Ikeda, Nobuhito</creatorcontrib><creatorcontrib>Kato, Masaru</creatorcontrib><creatorcontrib>Miake, Junichiro</creatorcontrib><creatorcontrib>Sakata, Shinji</creatorcontrib><creatorcontrib>Shiota, Goshi</creatorcontrib><creatorcontrib>Yoshida, Akio</creatorcontrib><creatorcontrib>Ninomiya, Haruaki</creatorcontrib><creatorcontrib>Higaki, Katsumi</creatorcontrib><creatorcontrib>Yamamoto, Kazuhiro</creatorcontrib><creatorcontrib>Shirayoshi, Yasuaki</creatorcontrib><creatorcontrib>Hisatome, Ichiro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Suzuki, Sayuri</au><au>Kurata, Yasutaka</au><au>Li, Peili</au><au>Notsu, Tomomi</au><au>Hasegawa, Akira</au><au>Ikeda, Nobuhito</au><au>Kato, Masaru</au><au>Miake, Junichiro</au><au>Sakata, Shinji</au><au>Shiota, Goshi</au><au>Yoshida, Akio</au><au>Ninomiya, Haruaki</au><au>Higaki, Katsumi</au><au>Yamamoto, Kazuhiro</au><au>Shirayoshi, Yasuaki</au><au>Hisatome, Ichiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Stabilization of Kv1.5 channel protein by bepridil through its action as a chemical chaperone</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>2012-12-05</date><risdate>2012</risdate><volume>696</volume><issue>1-3</issue><spage>28</spage><epage>34</epage><pages>28-34</pages><issn>0014-2999</issn><eissn>1879-0712</eissn><abstract>While bepridil has been reported to alter the stability of ion channel proteins, the precise mechanism of action remains unclear. We examined the effect of bepridil on the stability of Kv1.5 channel proteins expressed in COS7 cells. Bepridil at 0.3–30μM increased the protein level of Kv1.5 channels in a concentration-dependent manner. Chase experiments showed that bepridil delayed the degradation process of Kv1.5 channel proteins in the same manner as a proteasomal inhibitor, MG132, did. Bepridil increased the immunofluorescent signal of Kv1.5 channel proteins in the endoplasmic reticulum (ER) and Golgi apparatus and on the cell surface. The cell fraction experiment also showed bepridil-induced increases in Kv1.5 in the ER, Golgi apparatus, and the cell membrane. Bepridil at a lower concentration of 1μM had no effect on the proteasome activity in vitro. A blocker of the ultrarapid delayed-rectifier K+ channel current, 4-aminopyridine (4AP), abolished bepridil-induced increases in Kv1.5. Kv1.5-medicated membrane currents measured as 4AP-sensitive currents were increased by bepridil. Taken together, we conclude that bepridil stabilizes Kv1.5 proteins at the ER through an action as a chemical chaperone, thereby increasing the density of Kv1.5 channels in the cell membrane.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>23026372</pmid><doi>10.1016/j.ejphar.2012.09.025</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0014-2999
ispartof European journal of pharmacology, 2012-12, Vol.696 (1-3), p.28-34
issn 0014-2999
1879-0712
language eng
recordid cdi_proquest_miscellaneous_1139620864
source ScienceDirect Freedom Collection 2022-2024
subjects 4-Aminopyridine - pharmacology
Animals
Bepridil
Bepridil - pharmacology
Cercopithecus aethiops
Chemical chaperone
COS Cells
Endoplasmic Reticulum - drug effects
Endoplasmic Reticulum - metabolism
Golgi Apparatus - drug effects
Golgi Apparatus - metabolism
Kv1.5 channel
Kv1.5 Potassium Channel - metabolism
Membrane Transport Modulators - pharmacology
Potassium Channel Blockers - pharmacology
Protein stability
Rats
title Stabilization of Kv1.5 channel protein by bepridil through its action as a chemical chaperone
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T03%3A22%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Stabilization%20of%20Kv1.5%20channel%20protein%20by%20bepridil%20through%20its%20action%20as%20a%20chemical%20chaperone&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Suzuki,%20Sayuri&rft.date=2012-12-05&rft.volume=696&rft.issue=1-3&rft.spage=28&rft.epage=34&rft.pages=28-34&rft.issn=0014-2999&rft.eissn=1879-0712&rft_id=info:doi/10.1016/j.ejphar.2012.09.025&rft_dat=%3Cproquest_cross%3E1139620864%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c507t-d2ab9451c1ef9af8aadd3a041bff4ea7f8e8d2539456be2c2aee813036980d83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1139620864&rft_id=info:pmid/23026372&rfr_iscdi=true